IL2 and rheumatoid arthritis: Evidently, among those receiving ATG as induction agent, re-transplantations were more frequent with 28 (42%) patients having undergone at least one prior transplantation, while only 3 (4%) of those receiving IL-2 RA induction had a prior transplantation.